A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride

Drug Delivery

Volumn 16, Issue 2, 2009, Pages 82-91

  Mutalik, Srinivas ^a   Parekh, Harendra S ^a   Davies, Nigel M ^a   Udupa, Nayanabhirama ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Chemical enhancer; Skin permeation; Sonophoresis; Tizanidine; Transdermal

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ALCOHOL; CINEOLE; CITRAL; DIETHYLENE GLYCOL MONOETHYL ETHER; DIMETHYL SULFOXIDE; LIMONENE; MYRISTIC ACID ISOPROPYL ESTER; OLEIC ACID; PENETRATION ENHANCING AGENT; POLYSORBATE 80; PROPYLENE GLYCOL; TIZANIDINE; TRIACETIN;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; ENZYME STABILITY; INTRACELLULAR SPACE; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SKIN PERMEABILITY; SONOPHORESIS; SUSPENSION; ULTRASOUND;

1-OCTANOL; ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; BUFFERS; CLONIDINE; CYCLOHEXANOLS; CYCLOHEXENES; ETHANOL; MICE; MINERAL OIL; MONOTERPENES; MYRISTATES; OLEIC ACID; SKIN; SKIN ABSORPTION; SOLUBILITY; TERPENES; ULTRASONICS;

EID: 62249216550     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802605053     Document Type: Article

References (55)

1. Panchagnula R. (1997). Transdermal delivery of drugs. Indian J Pharmacol, 29, 140-56.
2. Ozguney SI, Karasulu YH, Kantarci G, Sözer S, Güneri T, Ertan G. (2006). Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS Pharm Sci Tech, 4, Article 88, E1-8.
3. Kost J, Mitragotri S, Langer R. (1999). Phonophoresis. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption, 3rd ed. Boca Raton: Taylor & Francis, 615-31.
4. Monti D, Giannelli R, Chetoni P, Burgalassi S. (2001). Comparison of the effect of ultrasound and of chemical enhancers on transdermal permeation of caffeine and morphine through hairless mouse skin in vitro. Int J Pharm, 229, 131-7.
5. Alvarez-Román R, Merino G, Kalia YN, Naik A, Guy RH. (2003). Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways. J Pharm Sci, 6, 1138-46.
6. Mitragotri S, Kost J. (2004). Low-frequency sonophoresis: a review. Adv Drug Deliv Rev, 5, 589-601.
7. Westfall TC, Westfall DP. (2005). Adrenergic agonists and antagonists. In: Brunton LL, ed. Goodmann and Gilman are The pharmacological basis of therapeutics. New York: Mc Graw-Hill medical publishing division, 237-95.
8. Moffat AC, Osselton MD, Widdop B. (2006). Clarke's analysis of drugs and poisons, 2nd Vol., 3rd ed. London: Pharmaceutical Press.
9. USP-NF. (2006). Reagents, Indicators and solutions. 29th (Asian) edition. USA: Rockville, MD. The United States pharmacopoeial convention, 3167-75.
10. Indian Pharmacopoeia. (1996). Reagents and solutions. Appendix 13, Vol 2, Ministry of Health and Family Welfare. Delhi, India: Government of India, A144-7.
11. Renata FVL, Collet JH, Bentley LB. (2000). Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int J Pharm, 200, 127-32.
12. Kim MK, Lee CH, Kim DD. (2000). Skin permeation of testosterone and its ester derivatives in rats. J Pharm Pharmacol, 52, 369-375.
13. Wells J. (2002). Pharmaceutical preformulation: the physicochemical properties of drug substances. In: Aulton ME, ed. Pharmaceutics. London: Churchill Livingstone, 113-51.
14. Carelli V, Di Colo G, Nannipieri E, Serafini MF. (1992). Enhancement effects in the permeation of alprazolam through hairless mouse skin. Int J Pharm, 88, 89-97.
15. Mura P, Faucci MT, Bramanti G, Corti P. (2000). Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci, 9, 365-72.
16. Gao S, Singh J. (1997). Mechanism of transdermal transport of 5-fluorouracil by terpenes: carvone, 1,8-cineole and thymol. Int J Pharm, 154, 67-77.
17. Babu RJ, Pandit JK. (2005). Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin. Drug Deliv, 3, 165-9.
18. Tezel A, Sens A, Tuchscherer J, Mitragotri S. (2002). Synergistic effect of low-frequency ultrasound and surfactants on skin permeability. J Pharm Sci, 1, 91-100.
19. Merino G, Kalia YN, Delgado-Charro MB, Potts RO, Guy RH. (2003). Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. J Contr Rel, 88, 85-94.
20. Boucaud A, Montharu JE, Machet L, Arbeille B, Machet MC, Patat FD, Vaillant L. (2001). Clinical, histologic, and electron microscopy study of skin exposed to low-frequency ultrasound. Anat Rec, 264, 114-9.
21. Subramanian G, Faisal M, Bhat V, Ranjith AK, Udupa N. (2006). Simultaneous RP-HPLC estimation of tizanidine and valdecoxib in tablets. Indian J Pharm Sci, 3, 391-3.
22. Krishnaiah YS, Satyanarayana V, Karthikeyan RS. (2002). Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J Pharm Pharm Sci, 2, 123-30.
23. Twist JN, Zatz JL. (1986). Influence of solvents on paraben permeation through idealized skin model membranes. J Soc Cosmetic Chem, 37, 429-44.
24. Kikwai L, Kanikkannan N, Babu RJ, Singh M. (2002). Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J Contr Rel, 2, 307-11.
25. Minghetti P, Cilurzo F, Casiraghi A, Montanari L, Fini A. (2007). Ex-vivo study of transdermal permeation of four diclofenac salts from different vehicles. J Pharm Sci, 4, 814-23.
26. Panchagnula R, Ritschel WA. (1991). Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies. J Pharm Pharmacol, 9, 609-14.
27. Jeans CW, Heard CM. (1999). A therapeutic dose of primaquine can be delivered across human skin from simple transdermal patches. Int J Pharm, 189, 1-6.
28. Zhao K, Singh J. (2000). Mechanism(s) of in vitro percutaneous absorption enhancement of tamoxifen by enhancers. J Pharm Sci, 6, 771-80.
29. Vaddi HK, Wang LZ, Ho PC, Chan SY. (2001). Effect of some enhancers on the permeation of haloperidol through rat skin in vitro. Int J Pharm, 212, 247-55.
30. Morimoto Y, Wada Y, Seki T, Sugibayashi K. (2002). In vitro skin permeation of morphine hydrochloride during the finite application of penetration enhancing system containing water, ethanol and l-menthol. Biol Pharm Bull, 1, 134-6.
31. Mayorga P, Puisieux F, Couarraze G. (1996). Formulation study of a transdermal delivery system of primaquine. Int J Pharm, 132, 71-9.
32. Kogan A, Garti N. (2006). Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci, 123-6, 369-85.
33. Mutalik S, Udupa N. (2002). Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin. Pharmazie, 12, 838-41.
34. Mutalik S, Udupa N. (2003). Effect of some penetration enhancers on the permeation of glibenclamide and glipizide through mouse skin. Pharmazie, 12, 891-4.
35. Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56, 603-18.
36. Aboofazeli R, Zia H, Needham TE. (2002). Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement. Drug Deliv, 9, 239-47.
37. Tipre DN, Vavia PR. (2002). Formulation optimization and stability study of transdermal therapeutic system of nicorandil. Pharm Dev Tech, 3, 325-32.
38. Ogiso T, Hata T, Iwaki M, Tanino T. (2001). Transdermal absorption of bupranolol in rabbit skin in vitro and in vivo. Biol Pharm Bull, 5, 588-91.
39. Parikh DK, Ghosh TK. (2005). Feasibility of transdermal delivery of fluoxetine. AAPS Pharm Sci Tech, 2, E144-9.
40. Garner ST, Israel BJ, Achmed H, Capomacchia AC, Abney T, Azadi P. (2007). Transdermal permeability of N-acetyl-d-glucosamine. Pharm Dev Technol, 2, 169-174.
41. Suwanpidokkul N, Thongnopnua P, Umprayn K. (2004). Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin. AAPS Pharm Sci Tech, 3, Article 48, E1-8.
42. Kim DD, Chien YW. (1995). Transdermal delivery of zalcitabine: in vitro skin permeation study. AIDS, 12, 1331-6.
43. Kanikkannan N, Kandimalla K, Lamba SS, Singh M. (2000). Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem, 6, 593-608.
44. Bauerova K, Matusova D, Kassai Z. (2001). Chemical enhancers for transdermal drug transport. Eur J Drug Metab Pharmacokinet, 1-2, 85-94.
45. Nokhodchi A, Sharabiani K, Rashidi MR, Ghafourian T. (2007). The effect of terpene concentrations on the skin penetration of diclofenac sodium. Int J Pharm, 335, 97-105.
46. Sherertz EF, Sloan KB, McTiernan RG. (1990). Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulations and a prodrug. Arch Dermatol Res, 282, 463-8.
47. Catz P, Friend DR. (1990). Transdermal delivery of levonorgestrel VIII. Effect of enhancers on rat skin, hairless mouse skin, hairless guinea pig skin, and human skin. Int J Pharm, 58, 93-102.
48. Gorukanti SR, Li L, Kim KH. (1999). Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation. Int J Pharm, 192, 159-72.
49. Kanikkannan N, Singh J, Ramarao P. (2001). In vitro transdermal ion-tophoretic transport of timolol maleate: effect of age and species. J Contr Rel, 71, 99-105.
50. Tezel A, Paliwal S, Shen Z, Mitragotri S. (2005). Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine, 29, 3800-7.
51. Kim TY, Jung DI, Kim YI, Yang JH, Shin SC. (2007). Anaesthetic effects of lidocaine hydrochloride gel using low frequency ultrasound of 0.5 MHz. J Pharm Sci, 1, 1-8.
52. Fang JY, Fang CL, Hong CT, Chen HY, Lin TY, Wei HM. (2001). Capsaicin and nonivamide as novel skin permeation enhancers for Indomethacin. Eur J Pharm Sci, 12, 195-203.
53. Tiwari SB, Pai RM, Udupa N. (2004). Influence of ultrasound on the percutaneous absorption of ketorolac tromethamine in vitro across rat skin. Drug Deliv, 1, 47-51.
54. Meidan VM, Walmsley AD, Irwin WJ. (1995). Phonophoresis: is it a reality? Int J Pharm, 118, 129-49.
55. Mitragotri S, Edwards DA, Blankschtein D, Langer R. (1995). A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci, 6, 697-706.